Term and postterm low-risk pregnancies: management schemes for the reduction of high rates of cesarean section.
BACKGROUND
We compare trends and current levels of cesarean section delivery by indication in some industrialized countries to help us understand factors underlying national differences in obstetric delivery practice and identify pathways to lower cesarean rates.


METHODS
In this report we describe the schemes employed at our Department for the management of low-risk at term and postterm pregnancies and list the most important motivations for increased cesarean section rate and remedies suggested to reduce high cesarean section rate. Moreover a randomized trial to assess the role of labor induction with PGE2 gel vs i.v. Oxytocin+Amniotomy in the management of prolonged pregnancy is being evaluated presently at our center.


METHODS
To date, 75 postterm pregnancies have been followed. Patients are enrolled at > or = 287 days (41 weeks). Intracervical PGE2 gel (0.5 mg) is used for cervical ripening. Induction of labor is randomly performed using intravaginal PGE2 gel (2 mg) or i.v. Oxytocin+Amniotomy.


RESULTS
Overall rates of 75% for spontaneous delivery, and 25% for cesarean section have been observed in our study group of prolonged pregnancies.


CONCLUSIONS
The accurate labelling of low- and high-risk pregnancy and the appropriate management of term and postterm pregnancy are two important steps for the reduction of a high rate of cesarean section.
Mancuso
S
S
Catholic University of Rome, Department of Obstetrics and Gynecology.
Ferrazzani
S
S
De Carolis
S
S
Carducci
B
B
De Santis
L
L
Caruso
A
A
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002585:Cesarean Section / Q000706:statistics & numerical data*; D015232:Dinoprostone / Q000008:administration & dosage; D005060:Europe / Q000453:epidemiology; D005260:Female; D005782:Gels; D006801:Humans; D007558:Italy / Q000453:epidemiology; D007751:Labor, Induced / Q000379:methods; D010121:Oxytocin / Q000008:administration & dosage; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology*; D011273:Pregnancy, Prolonged / Q000187:drug effects*; D012307:Risk Factors
D005782:Gels; D010121:Oxytocin; D015232:Dinoprostone